At a GIR conference in London, Zimmer Biomet’s Angela Main explained how she rebuilt trust in the company’s compliance program after the medical device maker got hit with a three-year monitorship.

Read Full Story: https://news.google.com/rss/articles/CBMilwFodHRwczovL2dsb2JhbGludmVzdGlnYXRp...